宝莱特股价涨5.15%,中信保诚基金旗下1只基金位居十大流通股东,持有105.5万股浮盈赚取46.42万元

Group 1 - The core point of the news is that Baolait Medical Technology Co., Ltd. experienced a stock price increase of 5.15%, reaching 8.99 yuan per share, with a total market capitalization of 2.379 billion yuan as of January 8 [1] - The company, founded on June 28, 1993, and listed on July 19, 2011, specializes in the research, production, sales, and service of medical device products, with main business revenue composition being 77.51% from blood dialysis products, 21.39% from monitoring devices, and 1.10% from other products [1] Group 2 - From the perspective of Baolait's top ten circulating shareholders, Citic Prudential Fund has a fund that entered the top ten shareholders, holding 1.055 million shares, which is 0.5% of the circulating shares, with an estimated floating profit of approximately 464,200 yuan [2] - The Citic Prudential Multi-Strategy Mixed Fund (LOF) A, established on June 16, 2017, has a latest scale of 1.133 billion yuan, with a year-to-date return of 0.9% ranking 7345 out of 8825 in its category, a one-year return of 49.64% ranking 2022 out of 8084, and a cumulative return since inception of 148.56% [2]

BIOLIGHT-宝莱特股价涨5.15%,中信保诚基金旗下1只基金位居十大流通股东,持有105.5万股浮盈赚取46.42万元 - Reportify